Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 574 followers
Latest posts
Last updated 13 days ago
GSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved by the European Commission
13 days ago
Prefilled syringe offers healthcare professionals a convenient administration option.
GSK announces positive results from B-Well 1 and B-Well 2 phase III trials for bepirovirsen, a potential first-in-class treatment for chronic hepatitis B
13 days ago
Bepirovirsen demonstrated a statistically significant and clinically meaningful functional cure rate
Exdensur (depemokimab) approved in Japan for severe asthma and chronic rhinosinusitis with nasal polyps
14 days ago
Exdensur is the first and only ultra-long-acting biologic in Japan for the...
Nucala (mepolizumab) approved in China for use in adults with chronic obstructive pulmonary disease (COPD)
15 days ago
Nucala is the first and only monthly biologic approved in China studied...
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
about 1 month ago
Voluntary agreement delivers on all four of President Trump’s requests and reduces...
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
about 1 month ago
SWIFT data included reduction in exacerbations requiring hospitalisation and/or emergency department visits...
Exdensur (depemokimab) approved in the UK for treatment of asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
about 1 month ago
Approval based on data from the SWIFT and ANCHOR phase III trials.
Nucala (mepolizumab) receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease (COPD)
about 1 month ago
Nucala is the only monthly biologic studied in a wide COPD population...
Depemokimab receives positive CHMP opinion for severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
about 1 month ago
If approved, depemokimab will be the first and only ultra-long-acting biologic in...
GSK’s RSV vaccine, Arexvy, receives positive CHMP opinion for all adults 18 years and older
about 1 month ago
Marketing authorisation expected in February 2026
Blujepa (gepotidacin) approved by US FDA as oral option for treatment of uncomplicated urogenital gonorrhoea (uGC)
about 1 month ago
Blujepa is the first in a new antibiotic class for the treatment...
GSK’227, a B7-H3-targeted antibody-drug conjugate, granted Orphan Drug Designation in small-cell lung cancer by the US FDA
about 1 month ago
Designation supported by early clinical data showing durable responses in certain types...